BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 34117503)

  • 1. Integrated I-125 Seed Implantation Combined with Transarterial Chemoembolization for Treatment of Hepatocellular Carcinoma with Main Portal Vein Tumor Thrombus.
    Wang W; Wang C; Shen J; Ren B; Yin Y; Yang J; Tang H; Zhu X; Ni C
    Cardiovasc Intervent Radiol; 2021 Oct; 44(10):1570-1578. PubMed ID: 34117503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and Feasibility of Helical I-125 Seed Implants Combined with Transcatheter Arterial Chemoembolization in Hepatocellular Carcinomas with Main Portal Vein Tumor Thrombus.
    Wang W; Shen J; Wang C; Ren B; Zhu X; Ni C
    Cardiovasc Intervent Radiol; 2019 Oct; 42(10):1420-1428. PubMed ID: 31187228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brachytherapy with Iodine-125 seeds for treatment of portal vein-branch tumor thrombus in patients with hepatocellular carcinoma.
    Hong D; Zhou Y; Wan X; Su H; Shao H
    BMC Cancer; 2021 Sep; 21(1):1020. PubMed ID: 34521375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative study of portal vein stent and TACE combined therapy with or without endovascular implantation of iodine-125 seeds strand for treating patients with hepatocellular carcinoma and main portal vein tumor thrombus].
    Wu LL; Luo JJ; Yan ZP; Wang JH; Wang XL; Zhang XB; Fang ZT; Zhang W
    Zhonghua Gan Zang Bing Za Zhi; 2012 Dec; 20(12):915-9. PubMed ID: 23522253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endovascular brachytherapy combined with stent placement and TACE for treatment of HCC with main portal vein tumor thrombus.
    Luo JJ; Zhang ZH; Liu QX; Zhang W; Wang JH; Yan ZP
    Hepatol Int; 2016 Jan; 10(1):185-95. PubMed ID: 26341514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined endovascular brachytherapy, sorafenib, and transarterial chemobolization therapy for hepatocellular carcinoma patients with portal vein tumor thrombus.
    Zhang ZH; Liu QX; Zhang W; Ma JQ; Wang JH; Luo JJ; Liu LX; Yan ZP
    World J Gastroenterol; 2017 Nov; 23(43):7735-7745. PubMed ID: 29209114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of therapeutics effects of transcatheter arterial chemoembolization combined with iodine-125 seed implantation and sorafenib for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis].
    Luo J; Zheng JP; Shao GL; Wen S; Guo LW; Zeng H; Zhang L; Qian CY; Hao WY
    Zhonghua Gan Zang Bing Za Zhi; 2018 Apr; 26(4):298-304. PubMed ID: 29996343
    [No Abstract]   [Full Text] [Related]  

  • 8. Safety and efficacy of endovascular implantation of a portal vein stent combined with iodine-125 seed-strips followed by transcatheter arterial chemoembolization with sorafenib for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis.
    Li S; Li L; Li B; Wang W
    Br J Radiol; 2020 Aug; 93(1112):20190279. PubMed ID: 32464068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Endovascular implantation of iodine-125 seeds strand and portal vein stenting followed by transcatheter arterial chemoembolization combined therapy with sorafenib for hepatocellular carcinoma with main portal vein tumor thrombus].
    Li WW; Dai ZY; Wan HG; Yao LZ; Zhu J; Li CL; Wang XJ; Pan J; Chen LZ
    Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(23):1838-42. PubMed ID: 27356794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety, efficacy, and survival of drug-eluting beads-transarterial chemoembolization vs. conventional-transarterial chemoembolization in advanced HCC patients with main portal vein tumor thrombus.
    Chen J; Lai L; Zhou C; Luo J; Wang H; Li M; Huang M
    Cancer Imaging; 2023 Jul; 23(1):70. PubMed ID: 37481660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transarterial chemoembolisation (TACE) combined with endovascular implantation of an iodine-125 seed strand for the treatment of hepatocellular carcinoma with portal vein tumour thrombosis versus TACE alone: a two-arm, randomised clinical trial.
    Yang M; Fang Z; Yan Z; Luo J; Liu L; Zhang W; Wu L; Ma J; Yang Q; Liu Q
    J Cancer Res Clin Oncol; 2014 Feb; 140(2):211-9. PubMed ID: 24374800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sorafenib With and Without Transarterial Chemoembolization for Advanced Hepatocellular Carcinoma With Main Portal Vein Tumor Thrombosis: A Retrospective Analysis.
    Zhang Y; Fan W; Wang Y; Lu L; Fu S; Yang J; Huang Y; Yao W; Li J
    Oncologist; 2015 Dec; 20(12):1417-24. PubMed ID: 26446238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of transcatheter arterial chemoembolization combined with either
    Li Y; Li H; Hu H; Yuan H; Zhao Y
    J Cancer Res Ther; 2020; 16(7):1691-1697. PubMed ID: 33565518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of D-TACE combined with endovascular brachytherapy for HCC with MPVTT.
    Huang W; Gong J; Wang Q; Wang Z; Liu Q; Liu J; Gu J; Ding X; Wu Z
    Front Oncol; 2022; 12():973357. PubMed ID: 36059634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of transarterial chemoembolization combined with lenvatinib, programmed death-1 inhibitor, and iodine-125 seed brachytherapy for hepatocellular carcinoma with portal vein tumor thrombosis.
    Lin LW; Yan LY; Ke K; Yang WZ; Lin JQ; Huang N
    Brachytherapy; 2023; 22(6):858-871. PubMed ID: 37574351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Endovascular placement of iodine-125 seed strand and self-expandable stent combined with transcatheter arterial chemoembolization for hepatocellular carcinoma with tumor thrombus in the main portal vein].
    Luo JJ; Yan ZP; Wang JH; Liu QX; Qu XD; Zhang W
    Zhonghua Zhong Liu Za Zhi; 2011 Jul; 33(7):535-9. PubMed ID: 22093634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endovascular brachytherapy combined with portal vein stenting and transarterial chemoembolization improves overall survival of hepatocellular carcinoma patients with main portal vein tumor thrombus.
    Yu TZ; Zhang W; Liu QX; Li WH; Ma JQ; Zhang ZH; Yang MJ; Wang JH; Chen B; Zeng SC; Luo JJ; Liu LX; Yan ZP
    Oncotarget; 2017 Feb; 8(7):12108-12119. PubMed ID: 28076848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transarterial chemoembolization plus lenvatinib versus transarterial chemoembolization plus sorafenib as first-line treatment for hepatocellular carcinoma with portal vein tumor thrombus: A prospective randomized study.
    Ding X; Sun W; Li W; Shen Y; Guo X; Teng Y; Liu X; Zheng L; Li W; Chen J
    Cancer; 2021 Oct; 127(20):3782-3793. PubMed ID: 34237154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Portal Vein Irradiation Stent Plus Chemoembolization versus External Radiotherapy Plus Chemoembolization in Hepatocellular Carcinoma with Portal Vein Tumour Thrombus: A Retrospective Study.
    Tan Z; Lu J; Zhu G; Chen L; Wang Y; Zhang Q; Pan T; Wang J; Guo J; Teng G
    Cardiovasc Intervent Radiol; 2021 Sep; 44(9):1414-1422. PubMed ID: 34131776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apatinib Combined With Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma and Portal Vein Tumor Thrombus: A Multicenter Retrospective Study.
    Fan W; Yuan G; Fan H; Li F; Wu Y; Zhao Y; Yao W; Wang Y; Xue M; Yang J; Li J
    Clin Ther; 2019 Aug; 41(8):1463-1476. PubMed ID: 31303279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.